文献速递MDS 与骨髓增殖性肿瘤贫血与红细胞疾病白血病

TGFβ在造血与髓系疾病中的作用

The role of TGFβ in hematopoiesis and myeloid disorders.
PubMed 文献 · Leukemia · 2019-02-28

本文综述TGFβ信号通路在胚胎发育与组织稳态中的作用及其经典下游级联,重点阐述该通路在造血调控及多种骨髓疾病发病中的意义,并讨论针对骨髓增生异常综合征(MDS)等血液病的TGFβ通路抑制剂治疗进展。

要点

  • TGFβ通路是造血微环境中调控不同细胞类型增殖与分化的重要通路。
  • TGFβ通路参与多种骨髓疾病的发病过程。
  • 针对TGFβ通路的新型抑制剂正在被开发用于MDS等血液病。

核心结论

  • TGFβ信号通路在造血调控及髓系疾病发病中具有重要作用,针对该通路的抑制剂在MDS等血液病中显示出有希望的治疗结果。

研究设计与样本

  • 综述:概述TGFβ通路及其在造血和髓系疾病中的作用,并讨论针对MDS的治疗干预。

主要发现

  • TGFβ信号通路参与多种骨髓疾病的发病过程。
  • TGFβ通路是造血区室中不同细胞类型增殖与分化的重要调节通路。
  • 针对TGFβ通路的新型抑制剂正在被开发用于包括MDS在内的多种血液病。
  • 文中讨论了在MDS中显示出有希望结果的治疗干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The role of transforming growth factor-β (TGFβ) signaling in embryological development and tissue homeostasis has been thoroughly characterized. Its canonical downstream cascade is well known, even though its true complexity and other non-canonical pathways are still being explored. TGFβ signaling has been described as an important pathway involved in carcinogenesis and cancer progression. In the hematopoietic compartment, the TGFβ pathway is an important regulator of proliferation and differentiation of different cell types and has been implicated in the pathogenesis of a diverse variety of bone marrow disorders. Due to its importance in hematological diseases, novel inhibitors of this pathway are being developed against a number of hematopoietic disorders, including myelodysplastic syndromes (MDS). In this review, we provide an overview of the TGFβ pathway, focusing on its role in hematopoiesis and impact on myeloid disorders. We will discuss therapeutic interventions with promising results against MDS.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Bataller A, Montalban-Bravo G, Soltysiak KA, et al. The role of TGFβ in hematopoiesis and myeloid disorders. Leukemia. 2019. PMID: 30816330. doi:10.1038/s41375-019-0420-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。